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Abstract
Acute exposure to high concentrations of H2S causes severe brain injury and long-term 
neurological disorders, but the mechanisms involved are not known. To better understand the 
cellular and molecular mechanisms involved in acute H2S-induced neurodegeneration we used a 
broad-spectrum proteomic analysis approach to identify key molecules and molecular pathways 
involved in the pathogenesis of acute H2S-induced neurotoxicity and neurodegeneration. Mice 
were subjected to acute inhalation exposure of up to 750 ppm of H2S. H2S induced behavioral 
deficits and severe lesions including hemorrhage in the inferior colliculus (IC). The IC was 
microdissected for proteomic analysis. Tandem mass tags (TMT) liquid chromatography mass 
spectrometry (LC-MS/MS)-based quantitative proteomics was applied for protein identification 
and quantitation. LC-MS/MS identified 598, 562, and 546 altered proteomic changes at 2 h, and 
on days 2 and 4 post-H2S exposure, respectively. Of these, 77 proteomic changes were statistically 
significant at any of the 3 time points. Mass spectrometry data were subjected to Perseus 1.5.5.3 
statistical analysis, and gene ontology heat map clustering. Expressions of several key molecules 
were verified to confirm H2S-dependent proteomics changes. Webgestalt pathway 
overrepresentation enrichment analysis with Panther engine revealed H2S exposure disrupted 
several biological processes including metabotropic glutamate receptor group 1 and inflammation 
mediated by chemokine and cytokine signaling pathways among others. Further analysis showed 
that energy metabolism, integrity of blood-brain barrier, hypoxic, and oxidative stress signaling 
pathways were also implicated. Collectively, this broad-spectrum proteomics data has provided 
important clues to follow up in future studies to further elucidate mechanisms of H2S-induced 
neurotoxicity.
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1. Introduction
Hydrogen sulfide (H2S) is a highly neurotoxic colorless gas with a “rotten egg” odor (Chou 
et al., 2016). It is as an environmental pollutant and an occupational hazard in a variety of 
industries including the oil and gas industry, intensive animal farming operations, sewer and 
waste water treatment plants, pulp and paper plants, and gas storage facilities, among several 
others (Chou et al., 2016). It is the second leading cause of fatal gas exposure in the 
workplace after carbon monoxide (Greenberg and Hamilton, 1998). It is estimated that there 
are > 1000 reports of human exposures to H2S each year in the United States (Chou et al., 
2016). Besides exposures under environmental and industrial settings, intentional 
H2Spoisoning for suicide has recently increased in Western and Asian societies (Morii et al., 
2010; Reedy et al., 2011). This is possible because raw chemical ingredients used to 
generate H2S for suicide are readily accessible in local stores (Morii et al., 2010). Also law 
enforcement and first responders called to help, as well as innocent bystanders are at risk of 
acute exposure to H2S (Sams et al., 2013). H2S was previously developed as a chemical 
weapon (Foulkes, 2009). There are concerns of potential nefarious use of this gas by 
terrorists, particularly in confined spaces, such as underground transit systems. For this 
reason, H2S has been identified as a priority chemical for research by the US Department of 
Homeland security (Security, 2017). The central nervous system (CNS) is the primary target 
organ of acute H2S-intoxication and neurotoxicity is the primary cause of death (Tvedt et al., 
1991a; Tvedt et al., 1991b; Snyder et al., 1995; Guidotti, 2015). Short-term effects of acute 
H2S poisoning by inhalation include knockdown, seizures, dyspnea, comma, and death. 
Currently, there is consensus that survivors of acute H2S poisoning develop neurological 
sequelae, which can be incapacitating and last many years often leading to disability (Tvedt 
et al., 1991a; Snyder et al., 1995; Guidotti, 2015). A number of neurological sequelae have 
been reported. These include dizziness, vertigo, ataxia with tendency to fall, insomnia, 
fatigue, anxiety, learning and cognition deficits, hearing impairment, recurrent seizures, lack 
of libido, and increased sensitivity to H2S, among others (Tvedt et al., 1991a; Tvedt et al., 
1991b; Snyder et al., 1995). Extreme cases progress to permanent vegetative states. 
Neurotoxicity, is manifested in individuals acutely exposed to H2S at concentrations > 500 
ppm (Snyder et al., 1995; Guidotti, 2015; Rumbeiha et al., 2016).
Currently, there are no FDA approved drugs for treatment of either short-term or long-term 
effects of acute H2S-induced neurotoxicity. The development of effective therapeutics 
requires a good understanding of the molecular mechanisms and pathways of acute H2S-
inducedneurotoxicity. These mechanisms remain largely unknown. There is an acute need 
for countermeasures for treatment of mass civilian casualties of acute H2S poisoning in the 
field, such as following catastrophic industrial meltdowns or intentional terrorist activities. 
Elucidating molecular mechanisms underlying H2S-induced neurotoxicity is essential in 
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identifying suitable therapeutic targets to counter both immediate and delayed neurotoxic 
effects of acute H2S poisoning in humans.
We recently developed an inhalation mouse model of acute H2S intoxication that exhibits 
key phenotypes of short- and long-term effects of acute H2S poisoning in victims and 
survivors (Anantharam et al., 2017). Briefly, this model is unique because normal walking 
mice without anesthesia are exposed to H2S by inhalation, recapitulating the typical 
exposure scenario, following accidents, or during suicide. Clinically, mice suddenly 
collapse, have seizures, and are dyspneic during exposure. Surviving mice manifest motor 
deficits on rotarod and open field tests, and developed neurodegeneration, faithfully 
recapitulating the human condition. The objective of this study was to use this mouse model 
to investigate proteomic changes following acute H2S-exposure to identify novel toxic 
mechanisms that could potentially be targeted for therapeutic intervention. These studies 
focused on the central inferior colliculus (IC), part of the brainstem, because our previous 
studies revealed this to be the most sensitive brain region to H2S-induced neurodegeneration 
(Anantharam et al., 2017). However, we also previously observed histopathological changes 
in other parts of the brain, especially the thalamus and cortex (Anantharam et al., 2017). 
This ground breaking H2S-study demonstrated, for the first time, that H2S exposure induces 
significant proteomic changes in the IC, including albumin (Alb) leakage, 
neuroinflammation, and oxidative stress, which collectively play an important role in the 
execution of H2S-induced neurotoxicity and neurodegeneration.
2. Materials and methods
2.1. Materials
H2S gas was purchased from Airgas (La Porte, TX). RNeasy mini kit was purchased from 
Qiagen (Germantown, MD). High Capacity cDNA RT kit were purchased from 
ThermoFisher Scientific (Waltham, MA). RT2 SYBR Green ROX qPCR Mastermix and 
primers for Gapdh were purchased from Qiagen (Valencia, CA). Primary antibodies against 
Alb, hypoxia inducing factor 1 alpha (Hif-1α), and Vimentin (Vim) were purchased from 
Cell signaling (Danvers, MA). Primary antibodies against nuclear factor-like 2 (Nrf2) and 3-
Oxoacid CoA Transferase 1 (Oxctl) were purchased from Abeam (Cambridge, MA). 
Primary antibody against Fas was purchased from SantaCruz Biotechnology (SantaCruz, 
CA). Primary antibody against NeuN was purchased from Millipore (Billerica, MA). U-
PLEX combo kit against TNF-α was purchased from Meso Scale Diagnostics (Rockville, 
MD).
2.2. Animals and treatment
This study was approved by Iowa State University Animal Care and Use Committee. Seven- 
to eight-week-old male C57 BL/6 J mice were used because previous studies from our lab 
showed that males were more sensitive than females. The mice were housed at room 
temperature of 20–22 °C under a 12-h light cycle, and a relative humidity of 35–50%. 
Protein rodent maintenance diet (Teklad HSD Inc., WI, US) and water were provided ad 
libitum. Prior to H2S exposure on day 1, all mice were acclimated to breathing air for 40 min 
for two consecutive days. Freely moving unanesthetized mice were exposed either to normal 
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breathing air (Control) or to 650–750 ppm H2S (H2S-treated) either once or to 2–7 short-
term exposures. Both breathing air and H2S were supplied from compressed gas cylinders. 
The inhalation dosage of H2S was selected basing on published literature indicating 
concentrations of H2S > 500 ppm are associated with knockdown and neurotoxicity in 
human (Snyder et al., 1995; Guidotti, 2015; Rumbeiha et al., 2016). Typically, humans are 
exposed once, but repeated exposures have been reported (Ahlborg, 1951). For purposes of 
studying the progression of neurotoxicity, separate groups of mice in this study were 
euthanized after receiving either only one or 2–7 acute exposures. For proteomic studies, the 
first batch of mice was terminated on the first day, day 1, only 2 h post exposure. Others 
were terminated on days 2 and 4. Negative controls were exposed to normal breathing air 
daily and euthanized on day 4. The gas exposure paradigm is summarized in Fig. 1. Animals 
were cared for in accordance with the Institutional Animal Care and Use committee 
guidelines.
2.3. Behavioral assessment
The VersaMax open field test was used to assess motor deficits induced by H2S. We used 
this test because previous studies in the lab had indicated it to be sensitive to acute H2S 
intoxication in this mouse model (Anantharam et al., 2017). Ataxia and other movement 
disorders are frequently reported neurological sequelae in survivors of acute H2S poisoning 
(Ahlborg, 1951; Tvedt et al., 1991a; Tvedt et al., 1991b). Spontaneous activity was 
measured using an automated computer device (Model RXYZCM-16; Accuscan, Columbus, 
OH, USA). The activity chamber’s dimensions are 40 × 40 × 30.5 cm, and it is made of 
Plexiglas with a Plexiglas lid. The lid has holes for ventilation. Data was analyzed using 
VersaMax Analyzer (Model CDA-8; Accuscan). Mice were placed in the activity chamber 
for acclimation 2 min prior to recording for 10 min. Vertical activity, horizontal activity, and 
distance traveled were measured.
2.4. Histopathology and immunohistochemistry
Mice were euthanized 2 h after the last H2S exposure. They were deeply anesthetized with a 
cocktail of 100 mg/kg BW ketamine and 10 mg/kg BW xylazine via intraperitoneal (IP) 
injection. The thoracic cavity was opened to expose the heart and fresh 4% 
paraformaldehyde (PFA, pH 7.4) was injected through the left ventricle. After perfusion, the 
skull was opened and brains were post-fixed in 4% PFA for 24–48 h before removal from 
the skull. Brains were processed in paraffin, sectioned at 5 μm, and stained with hematoxylin 
and eosin (H&E), and examined microscopically. Immunohistochemistry was used to 
visualize live and degenerating neurons. Neurons were stained with NeuN antibody 
(abl77487, Abeam, Cambridge, MA) using an indirect immunostaining protocol. 
Diaminobenzidine was used as chromogen. Stained sections were examined using a Nikon 
Eclipse Ci-L microscope equipped with a DS-Fi2 camera. For image analysis to count 
neurons, NeuN-positive cells (sites of DAB chromogen deposition) were enumerated in each 
of five 400× photomicrographs of the IC from mice exposed to H2S or breathing air, and the 
mean number of NeuN-positive cells were compared between groups. Degenerating and 
dying neurons were identified by Fluoro-Jade C staining. Briefly, deparaffinized, hydrated 
sections were incubated in 0.06% potassium permanganate solution for 10 min, rinsed for 2 
min in distilled water and incubated in a 0.0001% solution of Fluoro-Jade C (Histo-Chem, 
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Inc., Jefferson, AR) for 10 min at room temperature. Dark conditions were maintained after 
application of Fluoro-Jade C to prevent photobleaching. Sections were rinsed three times in 
distilled water, incubated at 4 °C in 6-diamidino-2-phenylindole (DAPI, Sigma, St. Louis, 
MO), rinsed, air-dried and cover slipped using DPX non-fluorescent mounting medium 
(Sigma, St. Louis, MO). Sections were examined using an EVOS FL Cell Imaging System 
(ThermoFisher Scientific).
2.5. Mass spectrometry proteomic analysis
Mice were euthanized by decapitation 2 h after the last exposure to H2S on days 1, 2 and 4 
for proteomics analysis, quantitative gene expression analysis by real-time PCR, and by 
Western blot. Following decapitation, brains were immediately removed from the skull. The 
IC was microdissected on ice and immediately flash-frozen using liquid nitrogen, and stored 
at −80 °C until further use. Samples were processed according to a previously published 
method with some modifications (Meade et al., 2015). Briefly, IC tissues were placed in 100 
μL of urea lysis buffer and homogenized with a handheld pestle homogenizer. Protein 
samples were further reduced and alkylated. Small aliquots of each sample were taken to 
measure protein concentration using the Bradford assay from Bio-Rad (Hercules, CA). The 
remaining samples were diluted and trypsin-digested overnight, followed by desalting using 
a C18 peptide trap from Michrom (Auburn, CA). The desalted samples were vacufuged prior 
to individual sample labeling using TMT-6plex labels according to the manufacturers’ 
instructions (Thermo Fisher Scientific, Waltham, MA). Labeled samples of each exposure 
group were combined with the control for sample comparison (Table 1). Peptides were 
separated on a Waters BEH C18 capillary column prior to online analysis using a 240-min 
linear increasing gradient of acetonitrile with 0.1% formic acid. Following elution from the 
column, ions were generated using 2.6 kV on a taper tip in a New Objective Nanosource and 
entered into an LTQ-OrbitrapVelos mass spectrometer (Thermo Fisher, San Jose, CA). A full 
scan was taken in the LTQ, followed by data-dependent MS/MS analysis of the top 6 peaks. 
MS/MS analysis included collision-induced dissociation (CID) in the LTQ for structural 
information and higher-energy collisional dissociation (HCD) in the Orbitrap for 
quantitation. MS/MS data were aligned and quantitated using MaxQuantl.5.4.1 (Cox and 
Mann, 2008) Analytics Platform with PTXQC (Bielow et al., 2016) quality control data 
management. Peptide alignment was executed with the mouse Uniprot protein database 
UP000000589_10090.fasta; enzyme: trypsin; carboxymethyl (C), and oxidation (M), FDR < 
1% based on peptide q-value under standard settings (see supplemental data). The secondary 
computational analysis was executed using Perseus 1.5.5.3 (Tyanova et al., 2016) for 
statistical rendering, and web-based software Morpheus for heatmap rendering. Prior to 
analysis of experimental samples, small aliquots of individually labeled control samples 
were analyzed to determine individual variations in controls. Due to low variability in the 
controls, a pooled control setting was used. Sample analysis included modification of the 
MaxQuant protein output list by normalization of individual TMT reporter ion intensities by 
division through the median intensity followed by determination of fold TMT expression 
ratios by division of individual experimental TMT values (126,127,128,129,and 130) 
through the TMT value (131) of the pooled control.
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2.6. Perseus statistical analysis
The previously modified Maxquant protein list was entered into the Perseus 1.5.5.3 software 
program followed by annotating Maxquant defined Swissprot protein accession numbers 
with mouse gene identifiers. Statistical analysis included one-sample t-tests of fold 
expression values by considering the deviation of samples from 1 fold expression (no change 
in TMT reporter ion intensities vs. control intensity values) using p < .05 as a criterion for 
significance. Scatter Plots were established by plotting one-sample t-test difference fold 
protein expression vs. –log one-sample t-test p value fold protein expression according to the 
associated Perseus tool set.
2.7. Morpheus Heatmap rendering
The Perseus processed protein list containing mouse gene identifiers, protein names and 
gene ontology (GO) biological process, one-sample t-test, levels of significantly and non-
significantly modulated proteins was entered into the web-based Morpheus heatmap-
rendering tool (https://software.broadinstitute.org/morpheus/). A gradient coloring scheme 
was applied to display upregulated (above 1.2 fold expression (in log2 display above 0.263), 
red color) vs. downregulated (below 0.83 fold expression (in log2 display below −0.263) 
blue color) protein nodes. White color nodes represent changes of non-modulated nodes to 
control levels (between 0.83 and 1.2 fold expression). Normalization of individual TMT 
reporter ion intensities was done by division through the median intensity followed by 
determination of fold TMT expression ratios by division of individual experimental TMT 
values (126,127,128,129,and 130) through the TMT value (131) of the pooled control. The 
cut-off limit of 1.2 fold was chosen because these individual values are already highly 
normalized expression values and the maximum fold values achieved were below 2.5. A 1.2 
fold cut-off value was used as in a previous publication (Meade et al., 2015). The heatmap 
was hierarchically clustered by Euclidean distance using row average linkage and grouping 
of rows by GO biological process. Functional enrichment analysis was performed using 
Webgestalt pathway overrepresentation enrichment analysis with Panther engine (http://
www.webgestalt.org/option.php). Up to ten highest probable pathways for each time point of 
H2S treatment data were presented.
2.8. Western blot assay
Microdissected tissue samples were lysed in modified RIPA lysis buffer (1% Triton X-100, 
ImM EDTA, 100 mM NaCl, ImM EGTA, 1 mM NaF, 20 mM Na4P207, 2mM Na3V04, 
10% glycerol, 0.1% SDS, 0.5% deoxycholate, 50 mM Tris-HCl, and pH 7.4) via sonication, 
followed by centrifugation as described previously (Kim et al., 2016). After protein 
concentration of samples were measured using the Bradford assay, equal amounts of protein 
samples were loaded to a 10–12% SDS-PAGE gel and transferred onto a nitrocellulose 
membrane. The membranes were blocked with 5% bovine serum albumin in TBS 
supplemented with 0.1% Tween-20. Specific primary antibodies were incubated with the 
membrane overnight at 4 °C. After rinsing thoroughly in PBS supplemented with 0.1% 
Tween-20, the membrane was incubated with secondary antibodies. β-Actin antibody was 
used for loading control. Immunoblot imaging was performed with an Odyssey Infrared 
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Imaging system (LI-COR, Lincoln, NE). ImageJ software (National Institutes of Health, 
Bethesda, MD) was used to quantify western blot bands.
2.9. Enzyme-linked immunosorbent assay
Microdissected tissue samples were immediately frozen. Samples were lysed in modified 
RIPA lysis buffer (150 mM NaCl, 20 mM Tris pH 7.5, 1 mM EGTA, 1 mM EDTA, 1% 
NP-40, 0.1% SDS) with protease inhibitors via sonication (Dalgard et al., 2012; Homji et al., 
2012). Lysed samples were centrifuged at 10,000 × g for 10 min at 4 °C. Expression of 
TNFα was measured using Meso Scale Discovery system following manufacturer’s 
protocol.
2.10. Quantitative real-time RT-PCR
Following exposure to H2S, tissues were dissected and immediately stored at −80 °C till 
analysis. Total RNA was extracted from frozen tissues using the RNeasy® Plus Mini kit with 
treatment of DNase I according to the manufacturer’s protocol. Validated primers for Gapdh 
(Qiagen, #PPR57734E) were used as the housekeeping gene controls. The threshold cycle 
(Ct) was calculated from the instrument software, and fold change in gene expression was 
calculated using the ΔΔt method as described earlier (Kim et al., 2016). The following 
primers were used to check the quantitative transcriptional level of Prkab1, Vim, and Ahsal; 
5′-TCCGATGTGTCTGAGCTGTC-3′ and 5′-CCCGTGTCCTTGTTCAAGAT-3′ for 
Prkab1 (Bandow et al., 2015), 5′-TCCACACGCACCTACAGTCT-3′ and 5′-
CCGAGGACCGGGTCACATA-3′ for Vim (Ulmasov et al., 2013), 5′-
CAGAGGGGCACTTTGCCACCA-3′ and 5′-CACGGCCTTCCATGCACAGCT-3′ for 
Ahsal.
2.11. Statistical analysis
Data were analyzed using Prism 4.0 (GraphPad Software, San Diego, CA). Non-paired 
Student’s t-test was used when two groups were being compared. Differences were 
considered statistically significant for p-values < 0.05. Data are represented as the mean ± 
S.E.M. of at least two separate experiments performed at least in triplicate.
3. Results
3.1. Acute exposure to H2S induces motor behavioral deficits and seizures in C57 black 
mice
Locomotor activities of mice were assessed on days 2, 4, and 6. Results indicated that the 
horizontal and vertical activities were decreased by > 50% and were statistically different in 
mice exposed to H2S compared to those that received breathing air (Fig. 2A and B). Total 
distance traveled was also decreased by > 50% and was also statistically different in H2S-
exposed mice compared to controls (Fig. 2C). Most importantly, mice exposed to H2S 
exhibited severe seizure activity. On day 1, during the first exposure, seizure activity was 
observed, on average, starting at 15 min of H2S exposure. More than 50% of mice had 
seizures at 40 min of exposure. We also observed that mice that were exposed to H2S on 
subsequent days were more sensitive to H2S than naive mice. For example, mice exposed to 
H2S more than once had seizures after only 5 min of H2S exposure compared to 15 min for 
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naive mice. Also, consistent with increased sensitivity, 40% of the mice exhibited seizures at 
10 min of H2S exposure on day 6 compared to about 40 min in naive mice on day 1. 
Collectively, these results indicate increased susceptibility of mice to H2S after each 
successive H2S exposures, suggesting that the toxic effects of H2S exposure are cumulative 
(Fig. 2D).
3.2. Acute hydrogen sulfide exposure induced brain damage
Motor behavioral deficits induced by exposure to H2S may be a sign of injury to the CNS. 
Therefore, histopathology was performed to identify the effects of H2S exposure in the IC. 
Mice were exposed to H2S as designated in Fig. 1. For this portion of the study, in order to 
assess the progression of neuropathology, mice were sacrificed at multiple time points (2 h, 
days 3 or 7). Microscopic examination of PFA-perfused brains revealed H2S-induced 
neurodegeneration and loss of neurons in the IC (Fig. 3A). By day 7, mice exposed to H2S 
exhibited severe lesions in the IC, with necrosis, vacuolar change, and infiltration by 
neuroglial cells. H2S exposure frequently induced hemorrhage in IC (Fig. 3B). In order to 
further characterize and quantify the loss of neurons, IC tissues were analyzed by 
immunohistochemical staining using the neuron specific marker, NeuN. On day 7, there was 
a marked loss of neurons in the IC of H2S-exposed mice, compared with the breathing air 
group. Enumeration of neurons in the IC revealed approximately a 70% loss of IC neurons 
by day 7 of H2S exposure (Fig. 3C and D) with infiltration by glial cells. However, in H2S 
exposed mice, neurons in the midbrain region adjacent to the IC appeared unaffected 
morphologically and glial cell numbers and activation state were not altered. 
Neurodegeneration was further confirmed using Fluoro-Jade C staining in the IC of H2S-
exposed mice (Fig. 3E). There was an increase in Fluoro-Jade C positive degenerating 
neurons in the IC. A reduction in numbers of NeuN positive cells and an increase in 
population of Fluoro-Jade C stained cells demonstrate H2S-induced selective loss of neurons 
and neurodegeneration in the IC.
3.3. Acute H2S exposure caused changes in the broad spectrum proteome
Proteomic profiles of the IC were determined using TMT peptide labeling coupled with 
LC/MS/MS analysis by comparison of the breathing air negative control group and the H2S 
exposed group is described in the methods section. Mass spectrophotometry analysis was 
able to identify 598, 562, and 546 altered proteins for 2 h, days, 2 and 4 of H2S exposure, 
respectively. Subsequent analyses showed alterations of protein expressions (Fig. 4, 
heatmap) with 36, 12 and 14 proteins being significantly downregulated (below 0.83 fold) 
and 9, 7, and 13 proteins being significantly upregulated (above 1.2 fold) compared to the 
control for 2 h and days 2 and 4 of H2S exposure, respectively. The cut-off limit of 1.2 fold 
was chosen because individual experimental TMT values for each sample were highly 
normalized as described above and has been used in previous publication (Meade et al., 
2015). A single H2S exposure, in which mice were euthanized only 2 h post exposure on day 
1, demonstrated the highest range of fold protein expression changes compared to the 
control with the majority of proteins being in the downregulation cluster. This was followed 
by day 2, in which mice received only 2 acute exposures, with equal distribution of 
upregulated and downregulated proteins, while mice euthanized on day 4 manifested the 
lowest range of fold changes with the least changes in the proteomic profile (Fig. 5A, B, C, 
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D, scatter plots). Several proteins including cytoplasmic FMR1-interacting protein 2 
(Cyfip2), Alb, and hemoglobin subunit proteins were increased on all three time-points, 
while some proteins including activator of HSP90 ATPase activity 1 (Ahsal) were 
consistently downregulated at the three time-points (Fig. 4 and Table 2). Scatter plots to 
show overall distribution of proteomic profile changes in the IC following H2S exposure are 
shown in Fig. 5. Fig. 5 display is a common method to display proteomics data.
3.4. Validation of proteomic changes of genes after H2S exposure
To confirm the observed changes in the IC proteomic profile following acute exposure to 
H2S, several genes were analyzed by Western blot or quantitative RT-PCR analysis. Mice 
were sacrificed on each designated time points to measure cellular response. The rationale 
for selection of proteomic changes for verification was based on a; proteomic changes which 
were consistently up or down regulated; and b) proteomic changes which fit the overall 
hypothesis of H2S-induced neurotoxicity.
H2S exposure consistently induced protein expression of Alb in proteomic analysis at 2 h, 
days 2 and 4. Alb, a major blood protein, is mainly produced in liver (Dodson et al., 2001). 
The Western blot analysis showed increased protein expression of Alb in the IC in H2S-
exposed mice (Fig. 6A). Oxctl is a homodimeric mitochondrial matrix enzyme in the 3-
oxoacid CoA-transferase gene family. Oxctl protein was increased in IC of H2S exposed 
mice (Fig. 6B). Vim encodes intermediate filaments and is part of cytoskeleton (Challa and 
Stefanovic, 2011). It signals neuroinflammation (Liu et al., 2014). To confirm potential H2S 
exposure dependent pro-inflammatory and ischemic effects, mRNA expression of Vim was 
measured. Vim mRNA expression demonstrated a steady increase at 2 h through day 4 (Fig. 
7B). This supports the increased protein expression of Vim at 2h. The increased mRNA 
expression of Vim was consistent with increased Vim protein expression on days 3 and 7 
(Fig. 6C).
Protein kinase AMP-activated non-catalytic subunit beta 1 (Prkab1) is known to correlate 
with calcium fluctuations as a measure of cellular calcium response (Yong et al., 2010). Due 
to unavailability of reliable antibody for the specific Prkab1, Prkab1 mRNA expression was 
analyzed as a means to measure the calcium-dependent cellular response following H2S 
exposure. Prkab1 mRNA expression was upregulated following H2S exposure on 2 h and 
days 2 and 4 which is in line with the mass spectrophotometry analysis observed 
upregulation of protein Kinase cAMP-activated catalytic subunit alpha (Prkca) and calcium 
activated protein kinase C beta (Prkacb) on exposure 2 h.
We observed downregulation of Ahsal at 2 h and on day 2 in proteomic profile analysis. 
Expression of Ahsal was examined by RT-PCR (Fig. 7C). Similar to the protein expression 
of Ahsal in proteomic profile analysis, mRNA expression of Ahsal demonstrated a 
significant 30–40% downregulation on 2 h and day 2, compared to the breathing air control 
group.
3.5. H2S exposure induced signaling pathways in IC
We further analyzed H2S-dependent alterations in the proteome using Webgestalt pathway 
overrepresentation enrichment analysis with Panther engine and displayed the 10 highest 
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probable pathways for each day of treatment, when applicable, by integrating gene cards 
information (www.genecards.org). Using this approach, we found that several molecular 
pathways were involved in H2S-induced neurotoxicity (Table 3). Acute exposure to H2S 
resulted in alteration of metabotropic glutamate receptor group I pathway, endothelin 
signaling pathway, inflammation mediated by chemokine and cytokine signaling pathway, 
and glycolysis at 2 h and on day 2. Fas signaling pathway, gonadotropin-releasing hormone 
receptor pathway, and cytoskeletal regulation by Rho GTPase pathway were altered on day 
4. Remarkably, biological pathways involved at 2h and on day 2 were similar, but patterns of 
altered biological pathways on day 4 were different (Table 3). The metabotropic glutamate 
receptor group 1 pathway, which was shown to be involved during early response of H2S 
exposure at 2h and on day 2, is consistent with our previous findings incriminating 
dysregulation of glutamate in H2S-induced neurotoxicity (Anantharam et al., 2017). These 
results also underscore the role of neuroinflammation and are consistent with our previously 
published data incriminating inflammation in the pathogenesis of H2S-induced neurotoxicity 
(Anantharam et al., 2017). In addition, expression of Fas was measured by Western blot to 
check activation of Fas signaling in H2S-induced neurotoxicity (Fig. 8A). The expression of 
Fas was significantly increased on day 3.
3.6. H2S exposure induced hypoxia, oxidative stress, and inflammatory signaling 
pathways in the IC
Hypoxia is implicated in H2S-induced neurotoxicity, but little or no evidence was presented 
before (Li et al., 2000; Shen et al., 2011). To check if H2S exposure activates hypoxic 
signaling, expression of Hif-1α was measured by Western blot analysis. Expression of 
Hif-1α was increased 2 fold after a one time exposure and 1.5 fold on days 3 and 7 (Fig. 
8B). To examine oxidative stress signaling in H2S-induced neurotoxicity, expression of Nrf2 
was measured by Western blot analysis (Fig. 8C). Protein expression of Nrf2 was 
significantly increased at 2 h and on day 3. Functional enrichment analysis showed 
inflammation response was involved in H2S-induced toxicity (Table 3). TNF-α is a key pro-
inflammatory cytokine. The expression of TNF-α was measured by ELISA and was found 
significantly increased on day 7 (Fig. 8D).
4. Discussion
Early events involved in acute H2S exposure or those leading to persistent neurological 
sequelae are not well known. Neurological sequelae among human survivors of acute H2S 
poisoning are widely reported (Matsuo et al., 1979; Tvedt et al., 1991a; Tvedt et al., 1991b; 
Kilburn, 1993; Snyder et al., 1995; Woodall et al., 2005). However, the exact cellular and 
molecular mechanisms underlying the pathogenesis of delayed neurological sequelae after 
acute H2S exposure are poorly understood. We have previously identified and herein 
confirmed that the IC in the brainstem region is highly sensitive to H2S-induced 
neurodegeneration (Anantharam et al., 2017).
The relative sensitivity of the IC to H2S-induced injury reflects the unique elements and cell 
populations in this region of the brain. We observed histologic features of neurodegeneration 
including neuronal death, and reactive gliosis in the IC starting on day 3. Massive cell 
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necrosis and glial scarring were noted in the IC on day 7. Immunohistochemistry with 
neuron specific antibody (NeuN) revealed severe neuronal loss in the IC following H2S 
exposure. Whereas neuronal loss was minimal in mice from the breathing air control group, 
there was > 70% loss in neurons in IC of mice exposed to H2S. In contrast, brain stem 
regions adjacent to the IC were shown to be relatively unaffected, indicating unique 
susceptibility of the IC region to H2S toxicity. The function of the IC is to integrate auditory 
and other sensory signals. IC is reportedly a region with high metabolic rate requirements 
(Ridgway et al., 2006; Houser et al., 2010) while it is also the most highly vascularized brain 
region (Gonzalez-Lima et al., 1997). H2S is a systemic metabolic toxicant that reportedly 
interferes with ATP synthesis. It is reasonable to infer that brain regions with high blood 
supply and metabolic rates such as the IC are more vulnerable to H2S-induced toxicity. 
Hearing loss is a frequently reported sequelae of acute H2S poisoning and these results are 
consistent with that observation.
In this study, we used proteomic analysis to define cellular and molecular mechanisms of 
H2S induced neurotoxicity and neurodegeneration during early stages of injury. Exposure to 
H2S induced significant proteomic changes in IC. Proteins commonly and constantly 
upregulated during H2S exposure were Cyfip2, hemoglobin subunit alpha (Hba), 
hemoglobin subunit beta-2 (Hbb-b2), and Alb. In contrast, Ahsal was consistently 
downregulated on 2h and days 2 and 4. The increased expression of Alb was confirmed by 
Western blot. Alb is a major blood protein and its presence in the IC suggests a breach of the 
blood-brain barrier (BBB), leading to protein leakage. Indeed, hemorrhage was observed in 
IC of mice following H2S exposure. Disruption of BBB triggered by a variety of factors has 
been reported to cause neuroinflammation (Erickson et al., 2012). This is a preliminary 
observation and the role of breach of BBB in H2S-induced neurotoxicity should be evaluated 
further in the future. The cause of the BBB breach is beyond the scope of this current study, 
but we also observed changes in other proteins triggered by hypoxic conditions including 
adenosine Kinase, Tropomodulin 2, vimentin, Neurogranin, and Poly(RC) binding protein 2. 
It is possible hypoxia induced the breach in the BBB.
Other key altered molecular biological pathways include metabotropic glutamate receptor 
group I pathway, inflammation mediated by chemokine and cytokine signaling pathway, and 
altered glycolysis. We have previously reported that H2S increases the glutamate:GABA 
ratio (Anantharam et al., 2017), an indication that H2S may activate glutamate receptors. 
These results suggesting a role for metabotropic glutamate I pathway in the pathogenesis of 
H2S-induced neurotoxicity is yet more evidence for glutamate-induced excitotoxicity. 
Glutamate excitotoxicity causes seizures (Jett, 2012).
H2S-induced neurotoxicity has been suggested to resemble brain injury caused by ischemic 
hypoxic conditions (Doujaiji and Al-Tawfiq, 2010; Rumbeiha et al., 2016). We observed 
increased Hif-1α protein expression in IC of H2S exposed mice. These results further 
support the role of hypoxia in H2S-induced neurotoxicity. The trigger for hypoxia is likely 
inhibition of cytochrome c oxidase in mitochondria, but this remains to be elucidated. Also, 
characterizing the downstream cascade of Hif-1α signaling pathway remains to be studied. 
Regardless, this is the first study to directly tie hypoxia to Hif-1α signaling in H2S-induced 
neurotoxicity. Previous studies have suggested neurofilament Nefl, and collapsing Response 
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Mediator Protein 3 (Dpysl4) as biomarkers of hypoxia and cerebral ischemia (Hou et al., 
2006; Lian et al., 2015). Dpysl4 is cleaved by activated calpain reaction in response to 
cerebral ischemia (Hou et al., 2006). Both Nefl and Dpysl4 were downregulated during H2S 
exposure. In addition, mass spectrophotometry analysis detected downregulation of 
phosphoglycerate mutase 2 (Pgam2), an ischemia biomarker, on day 1. This biomarker is 
suggested to correlate with the ischemic conditions (Li et al., 2012). Vimentin (Vim) has 
been shown as another biomarker for ischemia (Li et al., 2008). Mass spectrophotometry 
also detected a steady increase in protein and mRNA expression of the inflammatory and 
ischemia biomarker Vim for the entire duration of the study. These data collectively support 
H2S-dependent ischemia-like conditions during acute H2S exposures, further supporting the 
role of hypoxia as a mechanism of H2S-induced neurotoxicity.
It is well known that H2S inhibits cytochrome c oxidase which plays a crucial role in 
mitochondrial ATP synthesis (Nicholls and Kim, 1982; Dorman et al., 2002). Using 
variations of this animal model we have consistently shown inhibition of cytochrome c 
oxidase (Anantharam et al., 2017). In this proteomic study, expression levels of cytochrome 
c oxidase-related proteins were not changed, but mitochondrial cytochrome c oxidase 
subunit 2 (mt-Co2) and cytochrome c oxidase subunit 6C were decreased at 2 h and on day 
4, respectively, supporting the notion of potential impairment of energy production 
following H2S exposure. Several other proteins related to energy production were also 
altered. For instance, ATP synthase subunits Atp5j2 and ATP51 together with cytochrome C 
oxidases 6C were downregulated on days 2, and 4, respectively. In addition, citric acid cycle 
proteins malic enzyme (Mel) and phosphoglycerate mutase (Pgam2) were downregulated on 
2 h post a single dose. Oxctl was upregulated on day 2 and 4. Oxctl was upregulated and 
induced ATP production from ketone bodies when hepatocellular carcinoma were deprived 
of serum (Galluzzi and Kroemer, 2016). Increase of Oxctl during H2S exposure may indicate 
a switch from glucose metabolism to alternative sources of ATP production in IC of mice 
exposed acutely to H2S. Further studies are warranted to check whether Coxy6c, mt-Co2, 
and Oxctl are the bona fide targets of H2S toxicity. Collectively, these results suggest 
hypoxia, resulting in low oxygen tissue delivery, and dysregulation of cytochrome C related 
proteins, likely working in concert leading to energy deprivation and eventual neuronal death 
in the IC.
We have previously implicated neuroinflammation in this mouse model of acute H2S 
intoxication (Anantharam et al., 2017). Inflammation mediated by chemokine and cytokine 
signaling pathway was a key early finding in this study, and strongly upregulated starting 2h 
following a single acute exposure (Table 3). We have previously reported activated 
astrocytes and microglia following acute H2S exposure (Anantharam et al., 2017). Changes 
in immunogenic biomarkers represent one of earliest responses to cytotoxicity, and 
inflammation (Anantharam et al., 2017). Expression of TNF-α was shown to be significantly 
activated and increased in the IC on day 7 of H2S exposure. Moreover, anti-inflammatory 
protein macrophage migration inhibition factor (Mif) was downregulated on 2 h, and 
complement binding protein Clqbp was increased on day 4. Other pro-inflammatory related 
proteomic changes observed in this study include upregulations of Cyfip2 and nuclear 
hormone receptor and transcriptional repressor family (Nr1d2) which were observed 
throughout the course of the study. Also, increased expression of Cyfip2 was previously 
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shown by others to have a p53-response element in its promoter region and to be one of the 
direct targets of p53 (Jackson et al., 2007). In contrast, the anti-apoptotic and immunogenic 
protein Bcl2 associated athanogene (Bag5) was downregulated at 2 h. Endoplasmic 
reticulum stress-induced downregulation of Bag5 has previously reported (Bruchmann et al., 
2013; Gupta et al., 2016). Furthermore, expression of Fas was increased on day 3. Fas was 
previously responsible for initiating apoptotic signaling pathways and inflammation 
response (Cullen and Martin, 2015). The exact roles of these molecules in H2S-induced 
neurotoxicity remain to be studied further. However, collectively, these results are consistent 
with our previous observations that inflammation may play an important role in H2S-
induced neurotoxicity (Anantharam et al., 2017).
In summary, this seminal proteomic study of the IC from mice acutely H2S-intoxicated mice 
has yielded both novel and supporting results of our previous observations. H2S-induced 
neurotoxicity is complex. A summary of our current overarching hypothesis of acute H2S-
induced neurotoxicity is summarized in Fig. 9. We have explained how proteomic changes 
observed in this study fit key nodes of this summary scheme. We have also, to the extent 
possible, validated select proteomic changes using quantitative RT-PCR and Western blot 
analyses. Sufficient concordance was observed for the validated proteomic changes using 
transcript and/or protein expression. A very interesting observation was the close similarity 
in the top 10 proteomic pathways early in the course of H2S-intoxication (2 h and day 2). 
The study also uncovered novel pathways with a potential role in H2S-induced toxicity 
which we would not have predicted. These include the endothelin signaling pathway, the 
gonadotropin releasing hormone pathway, and the histamine H2 receptor mediated signaling 
pathway, among others summarized in Table 3. These likely play a role in any of the 
pathogenesis of multiple sequelae reported following acute H2S-intoxication, some of which 
are listed in Fig. 9. More research is certainly needed to study the role of these novel 
pathways in acute H2S-induced neurotoxicity.
5. Conclusion
In this study we examined the early effects of acute H2S-induced neurotoxicity in mice. The 
study focused on the IC, the most sensitive brain region to acute H2S poisoning. Results 
show that H2S modulated several proteins and biological pathways in the IC. Specifically, 
results suggest glutamate-induced excitotoxicity, immune mediated inflammatory response, 
pro-apoptosis mechanisms, and hypoxia/ischemia-like signaling to be involved in H2S-
induced neurotoxicity, among others. These results are in concert with our previously 
published observations, including dysregulated glutamate and GABA, mitochondrial injury, 
neuroinflammation and oxidative stress in the pathogenesis of acute H2S-induced 
neurotoxicity. An overall scheme of key events we hypothesize to be involved in the 
pathogenesis of acute H2S induced neurotoxicity is shown in Fig. 9. However, this research 
has also uncovered novel pathways which potentially may not fit the above scheme. This 
suggests that acute H2S-induced neurotoxicity is a complex process. Further research is 
recommended to better understand the singular and/or collective role of these potential 
mechanisms in H2S-induced mortality, neurotoxicity, and evolution of neurological 
sequelae.
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Fig. 1. 
Acute exposure paradigm of hydrogen sulfide in C57 black mice.
Mice were exposed to 765 ppm of H2S in a chamber for 40 min either once only (day 1) and 
for 15 min on the subsequent days up to day 7. Mice were sacrificed 2h post-H2S exposure 
on specified days of the study. Negative control mice were exposed to breathing air from a 
cylinder daily up to day 7. Separate groups of mice were sacrificed on days 1 (2 h post-
exposure), 3, and 7 for immunohistochemistry, Western blot assay, and ELISA analysis. 
Groups of mice for proteomics studies and quantitative RT-PCR analysis were sacrificed on 
days 1 (2 h post-exposure), 2 and 4.
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Fig. 2. 
Acute exposure to hydrogen sulfide induced motor deficits and seizures.
C57 black mice were exposed to H2S as shown in Fig. 1. Locomotor activity was measured 
using an automated VersaMax locomotor activity monitor for 10 min on days 2, 4, and 6. 
Horizontal activity (A), vertical activity (B), and total distance traveled (C) were analyzed 
between groups. For seizures, time to seizure and number of mice seizing were monitored 
(D). Asterisks (*, p < 0.05; **, p < 0.01) indicate statistically significant differences between 
H2S and breathing air negative control groups.
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Fig. 3. 
Neurodegeneration and necrosis in the IC of mice exposed to 650–750 ppm H2S in acute 
short-term repeated inhalation exposures over 7 days. Note the loss of neurons and 
development of clear vacuoles in the neuropil (arrow) on day 7 in mice exposed to H2S and 
the minimal morphologic effects to earlier H2S exposures or breathing air (A). H2S exposure 
induced hemorrhage (thick arrow) in the IC. An insert at higher magnification is included to 
show the hemorrhage. Hemorrhage was not seen in control mice (B). NeuN staining in 
brown color (arrow) of neurons (C). H2S caused marked and selective loss of neurons in the 
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IC (1000× magnification images, C), with retention of neurons in the regions surrounding 
the IC (200× magnification image) (C). Computer aided image analysis of NeuN 
immunostained sections reveals marked loss of neurons (D) in the IC of mice exposed to 
H2S (p < 0.001, t-test). Representative photomicrographs of mice exposed to breathing air or 
H2S, hematoxylin and eosin (A) and NeuN immunohistochemistry (C). Neurons in the IC 
region of the H2S exposed mice on day 7 were enumerated and compared to breathing air 
control (D). Degenerating neurons were visualized with Flouro-Jade C staining (E). Arrow 
indicates degenerative neurons. Neurodegeneration was not seen in the control group. (For 
interpretation of the references to color in this figure legend, the reader is referred to the web 
version of this article.)
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Fig. 4. 
Heatmap of changes in proteomic profile in the IC following acute H2S exposure.
Morpheus rendered Heatmap of determined changes in protein expression at 2 h and on days 
2 and 4. Hierarchical clustering by Euclidean distance, row average linkage and grouping of 
rows by gene ontology for biological process (GOBP). Heatmap displays fold expression 
values of five (2 h and day 2) or four (day 4) IC tissue samples, and average fold expression 
values, mouse gene identifiers (gene names), protein names, and GOBP. Red color indicates 
upregulation of protein expression (above 1.2 fold expression vs. control), whereas blue 
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color indicates downregulation of protein expression (below 0.83 fold expression vs. 
control) Grey color indicates proteins not identified. Protein expression change were 
converted into a log2 data display. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.)
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Fig. 5. 
Overall distribution of proteomic profile changes in the IC following H2S exposure.
A) Scatter Plot to display overall distribution of one-sample t-test differences in protein 
expression profiles vs. –Log one-sample t-test p values 2 h (red), day 2 (blue), and day 4 
(green) following H2S exposure. Scatter Plots of one-sample t-test fold protein expression 
differences vs. –Log one-sample t-test p values from B) 2 h, C) day 2, and D) day 4 of H2S 
exposure. One-sample t-test of significantly modulated proteins in the H2S exposure group 
vs. the control according to fold expression values are displayed with official mouse gene 
symbols in red. (For interpretation of the references to colour in this figure legend, the reader 
is referred to the web version of this article.)
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Fig. 6. 
Validation of selected protein expression changes in IC following H2S exposure. Protein 
expression was measured by Western blot analysis. Quantitative results are shown in graphs 
next to Western blot images. Samples were normalized to reference gene, β-Actin. Note the 
significant increase in Alb and Oxctl and a trend of increased Vim. Data are presented as the 
mean ± S.E.M. Asterisk (*p < 0.05) indicates a significant difference between H2S group 
and Control group.
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Fig. 7. 
Validation of expression changes of three genes at the mRNA level in IC following H2S 
exposure. The transcriptional level of three genes (A; Prkab1, B; Vim, C; Ahsal) was 
measured by quantitative PCR. Samples were normalized with the reference gene Gapdh. 
Data are presented as the mean ± S.E.M. Note that only a single acute exposure to H2S (2 h) 
was needed to cause upregulation of gene expression of PkAbl and Vim or downregulation 
of Ahsal gene expression. Asterisks (***p < 0.001, **p < 0.01, *p < 0.05) indicate a 
significant difference between H2S group and Control group.
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Fig. 8. 
Exposure to H2S induced hypoxic signaling, Fas signaling and inflammatory response in IC. 
Expression of Fas, Hif-1α, and Nrf2 in IC were analyzed by Western blot assay (A, B and 
C). Target protein expression was normalized to β-Actin. Quantification of Fas, Hif-1α, and 
Nrf2 expressions are shown graphically on the right. Expression of TNF-α was measured by 
ELISA (D). Note that TNF-α was significantly increased in the IC on day 7. Data are 
presented as the mean ± S.E.M. Asterisk (*p < 0.05) indicates a significant difference 
between H2S group and Control group.
Kim et al. Page 26
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2019 March 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 9. 
Overarching scheme of H2S induced neurotoxicity in the IC.
This figure is a summary of the overarching hypothesis of acute H2S-induced neurotoxicity. 
H2S activates glutamate excitotoxicity, mitochondrial injury, hypoxia, and a breach of the 
blood brain barrier, and mitochondrial injury trigger neuronal cell death, neuro-inflammation 
and oxidative stress which ultimately leads to neurodegeneration. Key pathways uncovered 
in the present study fit in various nodes in this overarching scheme.
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Table 3
Functional annotation of significantly modulated protein expression in the IC following H2S exposure at 2h, 
days 2, and 4. Table displays dysregulated molecular pathways and total number of proteins associated with 
GO-term definition. Note the similarity in pathways at 2 h and on day 2.
ID Name #Gene FDR
2h
P00041 Metabotropic glutamate receptor group I pathway 2 5.31E-01
P02772 Pyruvate metabolism 1 1.00E + 00
P00019 Endothelin signaling pathway 2 1.00E + 00
P02746 Heme biosynthesis 1 1.00E + 00
P00031 Inflammation mediated by chemokine and cytokine signaling pathway 3 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 3 1.00E + 00
P00024 Glycolysis 1 1.00E + 00
P04386 Histamine H2 receptor mediated signaling pathway 1 1.00E + 00
P05913 Enkephalin release 1 1.00E + 00
P00017 DNA replication 1 1.00E + 00
Day 2
P00041 Metabotropic glutamate receptor group I pathway 2 5.79E-01
P00017 DNA replication 2 5.79E-01
P02772 Pyruvate metabolism 1 1.00E + 00
P02746 Heme biosynthesis 1 1.00E + 00
P00019 Endothelin signaling pathway 2 1.00E + 00
P00031 Inflammation mediated by chemokine and cytokine signaling pathway 3 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 3 1.00E + 00
P00024 Glycolysis 1 1.00E + 00
P04386 Histamine H2 receptor mediated signaling pathway 1 1.00E + 00
P05913 Enkephalin release 1 1.00E + 00
Day 4
P00029 Huntington disease 2 1.00E + 00
P00020 FAS signaling pathway 1 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 2 1.00E + 00
P00016 Cytoskeletal regulation by Rho GTPase 1 1.00E + 00
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